INS and fatty liver disease: Patients with liver steatosis showed a significant increase in BMI, diastolic pressure, insulin, HOMA index, glycated hemoglobin (HbA1c), C-reactive protein, triglycerides, fatty liver index (FLI), and the presence of metabolic syndrome.